Beranda › Gangguan Depresi Mayor › Washington › Seattle
Uji klinis Gangguan Depresi Mayor di Seattle, WA
6 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Menerima pesertaFase 3
- Seattle Neuropsychiatric Treatment Center, Seattle
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, Seattle
Positive Processes and Transition to Health (PATH)
Menerima peserta
- University of Washington, Seattle
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Menerima pesertaFase 3
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Menerima pesertaFase 3
- Seattle Neuropsychiatric Treatment Center, Seattle
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
Menerima peserta
- University of Washington Medical Center, Seattle
Uji klinis Gangguan Depresi Mayor di kota lain
- New York City, NY37 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Tampa, FL17 studi
- Chicago, IL17 studi
- Houston, TX16 studi
- San Diego, CA16 studi
- Little Rock, AR14 studi
- Orange, CA13 studi
Studi lain di Seattle
- Kanker Paru Non-Sel Kecil53 studi
- Kanker (semua jenis)49 studi
- Kanker Prostat42 studi
- Leukemia Mieloid Akut40 studi
- Kanker Payudara39 studi
- Kanker Metastatik39 studi
- Kanker Kolorektal34 studi
- Kanker Paru33 studi
- Kanker Ovarium30 studi
- Mieloma Multipel22 studi
- Sindrom Mielodisplastik21 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.